Total Funding
76
65
Total FundingSeries B raised
Growth Score
-3 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
39766
Xanadu Bio is a nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that uses PACE platform technology.
- Bruce Turner: Founder, Chief Executive Officer and Chair, Board of Directors
About the Company
Xanadu Bio is a privately-held nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that uses PACE platform technology. The company develops an intranasal SARS-CoV-2 vaccine booster, after systemic vaccination, to protect against infection in the nasosinusal/upper airways, thus potentially reducing SARS-CoV-2
transmission in the community.
